VIM and acute myeloid leukemia: The analysis of 113 AML patients and 42 healthy donors identified that circular RNA originating from the Vimentin gene (circ-VIM) is significantly upregulated and associated with shorter survival in patients with non-acute promyelocytic leukemia and cytogenetically normal AML [144].